Economic Evaluation of Triflusal and Aspirin in the Treatment of Acute Myocardial Infarction

被引:0
作者
Josep Darbà
Iñaki Izquierdo
Caridad Pontes
Carlos Navas
Joan Rovira
机构
[1] University of Barcelona,Department of Economy
[2] Poligon Ind Riera de Caldes,Grupo Uriach
[3] SOIKOS,undefined
来源
PharmacoEconomics | 2002年 / 20卷
关键词
Aspirin; Acute Myocardial Infarction; Cerebral Haemorrhage; Transient Ischaemic Attack; Diagnosis Related Group;
D O I
暂无
中图分类号
学科分类号
摘要
Objective: To compare the costs to the Spanish healthcare system of 35 days’ treatment with triflusal (600 mg/day) and aspirin (300 mg/day) in patients with confirmed acute myocardial infarction within 24 hours of onset of symptoms.
引用
收藏
页码:195 / 201
页数:6
相关论文
共 46 条
[1]  
Villar F.(1998)Mortalidad cardiovascular en España y sus comunidades autónomas (1975–1992) Med Clin 110 321-7
[2]  
Banegas J.R.(1996)Treatment for acute myocardial infarction: overview of randomised clinical trials Eur Heart J 17 16-29
[3]  
Rodríguez F.(1996)Adjunctive drug therapy of acute myocardial infarction: evidence from clinical trials N Engl J Med 335 1660-7
[4]  
Yusuf S.(1990)Routine medical management of acute myocardial infarction Circulation 82 117-34
[5]  
Anand S.(1988)Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17187 cases of suspected acute myocardial infarction: ISIS-2 Lancet II 349-60
[6]  
Avezum A.(1994)Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various cathegories of patients BMJ 308 81-106
[7]  
Hennekens C.H.(1999)Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite 2-hydroxy-4-trifluoro methylbenzoic acid Mol Pharmacol 55 753-60
[8]  
Albert C.M.(1989)A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients N Engl J Med 321 501-7
[9]  
Godfried S.L.(1989)The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke Lancet 1 1215-20
[10]  
Yusuf S.(1987)The European Stroke Prevention Study (ESPS): principal end-points Lancet 2 1351-4